Pancreatic Cancer Research

ResearcherShimane UniversityActive in the last 2 years

Masaaki Hidaka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8191-6405; OpenAlex author ID A5055831731, A5071245370. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
58
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 2 papers

Papers 6

  1. Mesenteric Versus Conventional Approach During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma (MAPLE-PD trial): A Multicenter Randomized Controlled… Co-author DOI 10.1097/sla.0000000000006900↗
  2. Neoadjuvant Gemcitabine Plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score-matched Study. Last author DOI 10.21873/anticanres.18364↗
  3. Optimal treatment strategy for patients with pancreatic cancer having positive peritoneal cytology: A nationwide multicenter retrospective cohort study supervi… Co-author DOI 10.1002/jhbp.12074↗
  4. Patients With Pancreatic Cancer With Synchronous Liver Oligometastasis Show a Significant Long-Term Survival Benefit From Resection Under Specific Conditions: … Co-author DOI 10.1002/jhbp.12181↗
  5. Stress exacerbates pancreatic cancer both directly and indirectly by creating an immunosuppressive environment. Co-author DOI 10.1002/jhbp.1295↗
  6. Prognostic Impact of Relative Dose Intensity of Adjuvant Chemotherapy With S-1 on Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.15802↗

Closest collaborators

The 25 strongest of 58 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sohei Satoi · 3 shared papers, 2025–2026 · strength 0.58
  2. Takayuki Tanaka · 2 shared papers, 2022–2026 · strength 0.43
  3. Kenichi Hakamada · 2 shared papers, 2025 · strength 0.35
  4. Masamichi Mizuma · 2 shared papers, 2025 · strength 0.35
  5. Hiroshi Kurahara · 2 shared papers, 2025 · strength 0.35
  6. Satoshi Hirano · 2 shared papers, 2025 · strength 0.35
  7. Goro Honda · 2 shared papers, 2025 · strength 0.35
  8. Itaru Endo · 2 shared papers, 2025 · strength 0.35
  9. Hajime Matsushima · 2 shared papers, 2022–2023 · strength 0.30
  10. Hajime Imamura · 2 shared papers, 2022–2023 · strength 0.30
  11. Susumu Eguchi · 2 shared papers, 2022–2023 · strength 0.30
  12. Takashi Kishi · 1 shared paper, 2026 · strength 0.30
  13. Hideki Motobayashi · 1 shared paper, 2026 · strength 0.23
  14. Akimasa Nakao · 1 shared paper, 2026 · strength 0.23
  15. Keiko Kamei · 1 shared paper, 2026 · strength 0.23
  16. Yuji Kitahata · 1 shared paper, 2026 · strength 0.23
  17. Kenjiro Kimura · 1 shared paper, 2026 · strength 0.23
  18. Hiromitsu Hayashi · 1 shared paper, 2026 · strength 0.23
  19. Masafumi Nakamura · 1 shared paper, 2026 · strength 0.23
  20. Ryo Morimura · 1 shared paper, 2026 · strength 0.23
  21. Masayuki Sho · 1 shared paper, 2026 · strength 0.23
  22. Hiroki Yamaue · 1 shared paper, 2026 · strength 0.23
  23. Kenichiro Uemura · 1 shared paper, 2026 · strength 0.23
  24. Yuichi Nagakawa · 1 shared paper, 2026 · strength 0.23
  25. Yuko Mataki · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.